ARCHIVES

Why Did DeVita Resign MSK Post? Clash Of Style, Other Serious Issues Pointed To By Colleagues

This article is from The Cancer Letter archive.

Vol. 17 No. 23 | June 7, 1991

Download PDF Visit The Full Archive

Related Articles

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

Also in this 12-page issue: GM Cancer Research Foundation awards annual prizes to four scientists.

June 4, 2004

In Brief: Community Planning Contracts New Review, Implementation Projects Still In Negotiation

June 4, 1976

DCT Board reluctantly Okays Resources Contracts Recompetition, $6 of $10 Million Competitively

April 1, 1977

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

September 24, 1999